Trial intelligence / Profile preview

Immediate Post-Operative Anesthesia With Lidocaine or Bupivacaine

NCT06293807Phase 1Completed

Sponsor
UT Health San Antonio
Start
Jun 2022
Primary completion
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial in Periodontal disease (PD) comparing Xylocaine, Marcaine and Placebo (3 arms). Primary endpoints: Change in pain using Visual Analog Scale at 48 hours, Number of Ibuprofen administered at 48 hours and 1 more. Started Jun 2022; status: completed.

02

Drugs

lidocainebupivacaine
03

Conditions

Periodontal disease (PD)

Beyond the preview

Go deeper on NCT06293807.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06293807.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call